FBN2 and cancer: In addition, few studies have addressed the functional roles of the remaining 11 mutated genes (TTN, XIRP2, PCLO, CSMD3, FBN2, SYNE1, ABCA13, CUBN, DNAH3, DNAH8, and FSIP2) in cancer, which requires further investigation.